Rothschild & Co Asset Management US’s Haemonetics HAE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-38,493	Closed	-$3.45M	–	375
2018 Q2	$3.45M	Sell	38,493 -37,112	-49%	-$3.13M	0.04%	314
2018 Q1	$5.53M	Sell	75,605 -8,129	-10%	-$558K	0.06%	285
2017 Q4	$4.86M	Sell	83,734 -5,444	-6%	-$287K	0.05%	284
2017 Q3	$4M	Buy	89,178 +1,320	+2%	+$54.8K	0.04%	283
2017 Q2	$3.47M	Buy	87,858 +269	+0.3%	+$11K	0.04%	295
2017 Q1	$3.55M	Sell	87,589 -3,656	-4%	-$143K	0.04%	292
2016 Q4	$3.67M	Buy	91,245 +5,066	+6%	+$191K	0.05%	304
2016 Q3	$3.12M	Buy	86,179 +73	+0.1%	+$2.51K	0.05%	291
2016 Q2	$2.5M	Sell	86,106 -5,493	-6%	-$166K	0.05%	308
2016 Q1	$3.2M	Sell	91,599 -2,716	-3%	-$87.7K	0.06%	286
2015 Q4	$3.04M	Sell	94,315 -341,399	-78%	-$11.1M	0.06%	298
2015 Q3	$14.1M	Buy	435,714 +11,665	+3%	+$439K	0.28%	128
2015 Q2	$17.5M	Buy	424,049 +17,183	+4%	+$724K	0.32%	101
2015 Q1	$18.3M	Sell	406,866 -14,705	-3%	-$615K	0.35%	97
2014 Q4	$15.8M	Buy	+421,571	New	+$15.4M	0.31%	102